Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in Moderate to Severe TBI
NCT05531383Unknown
- Sponsor
- Minia University
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of memantine in traumatic brain injury (TBI) (2 arms), sponsored by Minia University. Primary endpoint: Prognosis of moderate to severe head injury at 7 days. Status: unknown.
02
Drugs
memantine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05531383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05531383.